Why the study?
Does the implantation of heparin-coated Palmaz-Schatz stents prevent stent thrombosis and improve event-free survival in stable patients with one significant de novo coronary lesion?
Does the implantation of heparin-coated Palmaz-Schatz stents prevent stent thrombosis and improve event-free survival in stable patients with one significant de novo coronary lesion?
Heparin-coated stents appear safe and effective in preventing acute thrombosis in stable patients with single de novo coronary lesions.
Supports safety of heparin-coated stents in stable single-lesion patients; leaves open randomized confirmation of benefit over uncoated stents.
The implantation of stents coated with polyamine and end-point-attached heparin in stable patients with one significant de novo coronary lesion is well tolerated, is associated with no (sub)acute stent thrombosis, and results in a favorable event-free survival after 6 months.
No takes yet. Share an insight, caveat, or question.
Serruys et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: